BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 8579905)

  • 1. The insulin-like growth factor system and the coupling of formation to resorption.
    Hayden JM; Mohan S; Baylink DJ
    Bone; 1995 Aug; 17(2 Suppl):93S-98S. PubMed ID: 8579905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function.
    Hill PA; Reynolds JJ; Meikle MC
    Endocrinology; 1995 Jan; 136(1):124-31. PubMed ID: 7828521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-1 stimulates release of insulin-like growth factor-I from neonatal mouse calvaria by a prostaglandin synthesis-dependent mechanism.
    Linkhart TA; MacCharles DC
    Endocrinology; 1992 Nov; 131(5):2297-305. PubMed ID: 1425428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor system components and the coupling of bone formation to resorption.
    Mohan S; Baylink DJ
    Horm Res; 1996; 45 Suppl 1():59-62. PubMed ID: 8805034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor (IGF)-I, -II, IGF binding proteins (IGFBP)-3, -4, and -5 levels in the conditioned media of normal human bone cells are skeletal site-dependent.
    Malpe R; Baylink DJ; Linkhart TA; Wergedal JE; Mohan S
    J Bone Miner Res; 1997 Mar; 12(3):423-30. PubMed ID: 9076585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoblasts and osteoclasts in adult human osteophyte tissue express the mRNAs for insulin-like growth factors I and II and the type 1 IGF receptor.
    Middleton J; Arnott N; Walsh S; Beresford J
    Bone; 1995 Mar; 16(3):287-93. PubMed ID: 7786631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects and differentiation activity of IGF-I, IGF-II, insulin and preptin on human primary bone cells.
    Bosetti M; Sabbatini M; Nicolì E; Fusaro L; Cannas M
    Growth Factors; 2013 Apr; 31(2):57-65. PubMed ID: 23410103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High serum IGFBP-2 is predictive of increased bone turnover in aging men and women.
    Amin S; Riggs BL; Melton LJ; Achenbach SJ; Atkinson EJ; Khosla S
    J Bone Miner Res; 2007 Jun; 22(6):799-807. PubMed ID: 17352648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin like growth factor-I: a critical mediator of the skeletal response to parathyroid hormone.
    Bikle DD; Wang Y
    Curr Mol Pharmacol; 2012 Jun; 5(2):135-42. PubMed ID: 21787292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The action of GH/IGF-I/IGFBP in osteoblasts and osteoclasts.
    Chihara K; Sugimoto T
    Horm Res; 1997; 48 Suppl 5():45-9. PubMed ID: 9434044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex pattern of insulin-like growth factor binding protein expression in primary rat osteoblast enriched cultures: regulation by prostaglandin E2, growth hormone, and the insulin-like growth factors.
    McCarthy TL; Casinghino S; Centrella M; Canalis E
    J Cell Physiol; 1994 Jul; 160(1):163-75. PubMed ID: 7517403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related changes in IGFBP-4 and IGFBP-5 levels in human serum and bone: implications for bone loss with aging.
    Mohan S; Farley JR; Baylink DJ
    Prog Growth Factor Res; 1995; 6(2-4):465-73. PubMed ID: 8817691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Function of matrix IGF-1 in coupling bone resorption and formation.
    Crane JL; Cao X
    J Mol Med (Berl); 2014 Feb; 92(2):107-15. PubMed ID: 24068256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple extracellular signals promote osteoblast survival and apoptosis.
    Hill PA; Tumber A; Meikle MC
    Endocrinology; 1997 Sep; 138(9):3849-58. PubMed ID: 9275074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of insulin-like growth factor-I (IGF-I) and IGF-II release from cultured neonatal mouse calvaria by parathyroid hormone, transforming growth factor-beta, and 1,25-dihydroxyvitamin D3.
    Linkhart TA; Keffer MJ
    Endocrinology; 1991 Mar; 128(3):1511-8. PubMed ID: 1999170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor binding protein production in bovine retinal endothelial cells.
    Giannini S; Cresci B; Manuelli C; Fujita-Yamaguchi Y; Romagnani P; Mohan S; Rotella CM
    Metabolism; 1997 Dec; 46(12):1367-79. PubMed ID: 9439529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A characteristic signature of insulin-like growth factor (IGF) axis expression during osteogenic differentiation of human dental pulp cells (hDPCs): Potential co-ordinated regulation of IGF action.
    Al-Khafaji H; Noer PR; Alkharobi H; Alhodhodi A; Meade J; El-Gendy R; Oxvig C; Beattie J
    Growth Horm IGF Res; 2018; 42-43():14-21. PubMed ID: 30071469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of the serum stimulatory components of the insulin-like growth factor (IGF) system (IGF-I, IGF-II, IGF binding protein [BP]-3, and IGFBP-5) in age-related (type II) femoral neck osteoporosis.
    Boonen S; Mohan S; Dequeker J; Aerssens J; Vanderschueren D; Verbeke G; Broos P; Bouillon R; Baylink DJ
    J Bone Miner Res; 1999 Dec; 14(12):2150-8. PubMed ID: 10620075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoclast formation together with interleukin-6 production in mouse long bones is increased by insulin-like growth factor-I.
    Slootweg MC; Most WW; van Beek E; Schot LP; Papapoulos SE; Löwik CW
    J Endocrinol; 1992 Mar; 132(3):433-8. PubMed ID: 1564429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-I molecular pathways in osteoblasts: potential targets for pharmacological manipulation.
    Govoni KE
    Curr Mol Pharmacol; 2012 Jun; 5(2):143-52. PubMed ID: 21787291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.